2008
DOI: 10.1124/dmd.107.020271
|View full text |Cite
|
Sign up to set email alerts
|

Biodistribution of Radiolabeled Ethanol in Rodents

Abstract: ABSTRACT:The biodistribution of [1- 14

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
1
0
2

Year Published

2015
2015
2023
2023

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 27 publications
(25 reference statements)
0
1
0
2
Order By: Relevance
“…Information about the total fate of drug-related material and routes of excretion can be obtained from mass balance studies (Park et al, 1997; Schadt et al, 2012). QWBA studies provide the tissue distribution and pharmacokinetics data required for new drug registration and for predicting human exposure to radioactivity during clinical radiolabeled mass balance studies (Gifford et al, 2008; Wang et al, 2011). Both QWBA and mass balance studies are required for regulatory filings of a new drug entity and for projecting tissue dosimetry in human mass balance studies (Scicinski et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…Information about the total fate of drug-related material and routes of excretion can be obtained from mass balance studies (Park et al, 1997; Schadt et al, 2012). QWBA studies provide the tissue distribution and pharmacokinetics data required for new drug registration and for predicting human exposure to radioactivity during clinical radiolabeled mass balance studies (Gifford et al, 2008; Wang et al, 2011). Both QWBA and mass balance studies are required for regulatory filings of a new drug entity and for projecting tissue dosimetry in human mass balance studies (Scicinski et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…Os 10% restantes são eliminados de forma inalterada pelos pulmões, rins, suor e saliva (Paton, 2005;Gifford et al, 2008).…”
Section: Revisão De Literaturaunclassified
“…Em ratos, a saturação desta biotransformação é de aproximadamente 700 mg/kg/h. O tempo de meia-vida farmacológica após a ministração intravenosa de 250 mg/kg nestes animais é de 30 minutos (Gifford et al, 2008 (Edenberg, 2007;Sloan et al, 2008;Strat et al, 2008 cefaléia pulsante e taquicardia (Edenberg, 2007).…”
Section: Revisão De Literaturaunclassified